title: HSV-1 cutaneous infection in a patient with Hodgkin's lymphoma treated with brentuximab vedotin.
authors.forename: Matteo
authors.initials: M
authors.lastname: Bassetti
authors.forename: Davide
authors.initials: D
authors.lastname: Pecori
authors.forename: Elda
authors.initials: E
authors.lastname: Righi
authors.forename: Federica
authors.initials: F
authors.lastname: Brillo
authors.forename: Barbara
authors.initials: B
authors.lastname: Cadeo
authors.forename: Sergio
authors.initials: S
authors.lastname: Venturini
authors.forename: Marianna
authors.initials: M
authors.lastname: Chiozzotto
authors.forename: Francesco
authors.initials: F
authors.lastname: Zaja
mesh_terms: D000328:Adult; D000079963:Brentuximab Vedotin; D006561:Herpes Simplex / Q000188:drug therapy*; D018259:Herpesvirus 1, Human / Q000187:drug effects*; D006689:Hodgkin Disease / Q000821:virology*; D006801:Humans; D018796:Immunoconjugates / Q000627:therapeutic use*; D008297:Male; D012867:Skin / Q000187:drug effects / Q000821:virology*; D012874:Skin Diseases, Infectious / Q000188:drug therapy* / Q000821:virology
chemical_list: D018796:Immunoconjugates; D000079963:Brentuximab Vedotin